Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Tt, Batysheva"'
Autor:
TT Batysheva, IV Kanivets, DI Grebenkin, OB Kondakova, NV Zhurkova, EV Khrustaleva, AA Lialina
Publikováno v:
Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::290d1263dfe1943e127fb27865078ca9
https://doi.org/10.1136/archdischild-2021-europaediatrics.81
https://doi.org/10.1136/archdischild-2021-europaediatrics.81
Publikováno v:
Europe PubMed Central
Neurological diseases, mental disorders and inherited developmental abnormalities held a prominent place in the structure of primary children disability. Children cerebral palsy is the main cause of children disability, its prevalence reaching 2-3.5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::55510cf6faa528332120314625f15e94
https://pubmed.ncbi.nlm.nih.gov/23330194
https://pubmed.ncbi.nlm.nih.gov/23330194
Autor:
Tt, Batysheva, Ov, Otcheskaia, Aa, Khozova, Pa, Ganzhula, Ka, Zaĭtsev, Kamchatnov Pavel, An, Boĭko
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ee238a48498e4d273aa2d00be1850e87
https://pubmed.ncbi.nlm.nih.gov/22027606
https://pubmed.ncbi.nlm.nih.gov/22027606
Publikováno v:
Europe PubMed Central
The study included 54 patients with multiple sclerosis, aged from 23 to 53 years (mean age 37.7 +/- 8.5 years). To reduce muscle tension, 34 patients of the main group received tizanidine with the modified release of active substance (sirdalud MR) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::39fba8f42695a1ae4d73e7e188a5bc91
https://pubmed.ncbi.nlm.nih.gov/21322181
https://pubmed.ncbi.nlm.nih.gov/21322181
Publikováno v:
Europe PubMed Central
We studied efficacy and tolerability of the combined drug omaron (25 mg of cinnarizine and 400 mg of piracetam in one tablet) in patients with multiple sclerosis. The dosage of the drug was 1 tablet 3 times a day during 12 weeks in 33 patients (mean
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ce0c11d0a9021b49f41e13665a776074
https://pubmed.ncbi.nlm.nih.gov/21183917
https://pubmed.ncbi.nlm.nih.gov/21183917
Publikováno v:
Europe PubMed Central
External counterpulsation (ECP) - is a non-invasive method of treatment providing the increase of perfusion pressure in coronary and cerebral arteries during diastole and the decrease of vascular resistance during systole. Efficacy of this method in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::486fb5c085a5b8b7b85a41d12f1d7c06
https://pubmed.ncbi.nlm.nih.gov/19672225
https://pubmed.ncbi.nlm.nih.gov/19672225
Autor:
Tt, Batysheva, Kamchatnov Pavel, Me, Guseva, Ka, Zaĭtsev, Zhuravleva EIu, Ev, Kostenko, Os, Nesterova, Ov, Otcheskaia, An, Boĭko
Publikováno v:
Europe PubMed Central
An open comparative study of efficacy and tolerability of velaxin (venlafaxine with prolonged action), which has been prescribed in a single dosage of 75 mg daily during 8 weeks, included 47 patients with subacute and chronic spondylogenic dorsopathy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f797d9aeb9d242b5e85a085b4897c4e8
https://pubmed.ncbi.nlm.nih.gov/19491816
https://pubmed.ncbi.nlm.nih.gov/19491816
Autor:
Tt, Batysheva, Ov, Otcheskaia, On, Nesterova, Ln, Lisinker, La, Bobina, Am, Ismailov, Rk, Shekkhirimov, Zhuravleva EIu, Kamchatnov Pavel, An, Boĭko
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::80928d0e3f9a098b18440f33e954e151
https://pubmed.ncbi.nlm.nih.gov/19255983
https://pubmed.ncbi.nlm.nih.gov/19255983
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::48f07c4675eea2289e11fd1693698b82
https://pubmed.ncbi.nlm.nih.gov/16447553
https://pubmed.ncbi.nlm.nih.gov/16447553
Autor:
An, Boĭko, Tt, Batysheva, Mv, Mel Nikova, Ov, Boĭko, Bt, Mugutdinova, Tp, Gorina, Vv, Ovcharov, Olga Bykova, Nf, Popova, Ei, Gusev
Publikováno v:
Europe PubMed Central
The aim of the study was to describe the atrophy of the thalamus in young patients with active relapsing multiple sclerosis (MS) treated with cerebrolysin. Eighteen MS patients (mean age 20.10±0.45 years) with disease onset in childhood or adolescen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::46e76355afdc45b0194e575595af0299
http://europepmc.org/abstract/med/23528602
http://europepmc.org/abstract/med/23528602
